Skip to main content

Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients

Journal of Neural Transmission volume 104, pages 441–449 (1997)Cite this article

Summary

The concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism (VP) was compared to that in patients with Parkinson's disease (PD) and controls. Compared to the controls, the concentration of tyrosine was significantly higher, and the concentration of L-dopa and 3-O-methyldopa (3-OMD) was significantly lower in both VP and PD patients. The balance between the 3-OMD/L-dopa and dopamine (DA)/L-dopa ratios was changed in favor of 3-OMD/L-dopa in both VP patients and PD patients suggesting the preservation of a compensatory mechanism. All these changes were less marked in VP patients than in PD patients. A remarkable finding was that in contrast to PD patients the concentration of DA and norepinephrine (NE) was significantly higher in VP patients than in the controls. The decrease in the concentration of 5-hydroxytryptamine (5-HT) was significantly greater in VP patients than in PD patients. In PD patients, the concentration of DA, NE, and 5-HT showed significant correlation with the severity of motor symptoms. In VP patients, the concentration of 5-HT alone showed significant correlation with the severity of motor symptoms and cognitive dysfunction. These findings suggest that VP patients may have similar disturbances in the DA synthesis pathway as PD patients, but differ from PD patients in that the concentrations of DA and NE are elevated and the decrease in the 5-HT concentration is greater in VP patients.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  • Agid Y, Javoy-Agid F, Ruberg M (1987) Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden CD, Fahn S (eds) Movement disorders, vol 2. Butterworth, London, pp 166–230

    Google Scholar 

  • Alvord EC (1968) The pathology of parkinsonism. In: Minckler J (ed) Pathology of the nervous system, vol 1. McGraw-Hill, New York, pp 1152–1160

    Google Scholar 

  • Bernheimer H, Birkmayer W, Hornykiewicz O (1961) Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom. Klin Wochenschr 39: 1056–1059

    PubMed  Google Scholar 

  • Callaway CW, Nichols DE, Paulus MP, Geyer MA (1991) Serotonin release is responsible for the locomotor hyperactivity in rats induced by derivatives of amphetamine related to MDMA. In: Fozard JR, Saxena PR (eds) Serotonin: molecular biology, receptors and functional effects. Birkhäuser, Basel, pp 491–505

    Google Scholar 

  • Chang CJ, Ishii H, Yamamoto H, Yamamoto T, Spatz M (1993) Effects of cerebral ischemia on regional dopamine release and D1 and D2 receptors. J Neurochem 60: 1483–1490

    PubMed  Google Scholar 

  • Critchley M (1929) Arteriosclerotic parkinsonism. Brain 52: 23–83

    Google Scholar 

  • Denny-Brown D (1962) The basal ganglia and their relation to disorders of movements. Oxford University Press, Oxford, pp 37–44

    Google Scholar 

  • Farley IJ, Hornykiewicz O (1976) Noradrenaline in subcortical brain regions of patients with Parkinson's disease and control subjects. In: Birkmayer W, Hornykiewicz O (eds) Advances in parkinsonism. Roche, Basel, pp 178–185

    Google Scholar 

  • Fahn S (1995) Parkinsonism. In: Rowland LP (ed) Merritt's textbook of neurology, 9th ed. Williams & Wilkins, Baltimore, pp 713–730

    Google Scholar 

  • Fahn S, Elton RL, members of the UPDRS development committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease, vol II. MacMillan Healthcare Information, Florham Park NJ, pp 293–304

    Google Scholar 

  • FitzGerald PM, Jankovic J (1989) Lower body parkinsonism: evidence for vascular etiology. Mov Disord 4: 249–26026

    PubMed  Google Scholar 

  • Foerster O (1909) Die arteriosklerotische Muskelstarre. All Z Psychiat 66: 902–913

    Google Scholar 

  • Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17: 427–442.

    PubMed  Google Scholar 

  • Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42: 1142–1146

    PubMed  Google Scholar 

  • Izumi J, Inagaki M, Kiuchi Y, Matsumoto M, Yamazaki Y, Morioka D, Usami S, Oguchi K (1993) Sustained increase in adrenergic activity in gerbil striatum following transient ischemia. J Pharmacol 63: 143–149

    Google Scholar 

  • Jellinger K (1989) Pathology of Parkinson's syndrome. In: Calne DB (ed) Drugs for the treatment of Parkinson's disease. Springer, Berlin Heidelberg New York Tokyo, pp 47–112

    Google Scholar 

  • Kato S, Simogaki H, Onodera A, Ueda H, Oikawa K, Ikeda K, Kosaka A, Imai Y, Hasegawa K (1991) Development of the revised version of Hasegawa's Dementia Scale (HDS-R) (in Japanese). Jpn J Geriat Psychiat 2: 1339–1347

    Google Scholar 

  • Lhermitte MMJ, Cornil L (1921) Syndrome strié á double expression symptomatique, pseudo-bulbaire et parkinsonienne. Rev Neurol 37: 299–305

    Google Scholar 

  • Marie P (1901) Des foyers lacunaires de disintegration et de differents autres états cavitaires du cerveau. Rev Med Paris 21: 281–298

    Google Scholar 

  • Morgante L, Rocca WA, Di Rosa AE, De Domenico P, Grigoletto F, Meneghini F, Reggio A, Savettieri G, Castiglione MG, Patti F, Di Perr R, for the Sicilian Neruo-Epidemiologic Study (SNES) Group (1992) Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 42: 1901–1907

    PubMed  Google Scholar 

  • Murrow RW, Schweiger GD, Kepes JJ, Koller WC (1990) Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation. Neurology 40: 897–900

    PubMed  Google Scholar 

  • Nagasawa H, Araki T, Kogure K (1992) Autoradiographic analysis of second messenger and neurotransmitter receptor bindings in the strionigral system of the postischemic rat brain. J Neurosci Res 33: 485–492

    PubMed  Google Scholar 

  • Nagatsu T, Wakui Y, Kalo T, Fujita K, Kondo T, Yokochi F, Narabayashi H (1982) Dopamine beta-hydroxylase activity in cerebrospinal fluid of Parkinsonian patients. Biomed Res 3: 95–98

    Google Scholar 

  • Parkes JD, Marsden CD, Rees JE, Curson G, Kantamaneni BD, Knill-Jones R, Akabar A, Das S, Kataria M (1974) Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and responses to levodopa. Q J Med 18: 49–61

    Google Scholar 

  • Pastuszko A, Wilson DF, Erecinska M (1982) Neurotransmitter metabolism in rat brain synaptosomes: effect of anoxia and pH. J Neurochem 38: 1657–1667

    PubMed  Google Scholar 

  • Przedborski S, Kostic V, Jackson-Lewis V, Lud Cadet J, Bruke RE (1991) Effects of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: a quantitative autoradiographic study. J Neurochem 57: 1951–1961

    PubMed  Google Scholar 

  • Sarna G (1991) Brain indole metabolism assessed using in vivo dialysis. In: Schwarcz R, Young SN, Brown RR (eds) Kynurenine and serotonin pathways. Progress in tryptophan research. Plenum Press, New York, pp 63–80 (Adv Exp Med Biol, vol 294)

    Google Scholar 

  • Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275: 321–328

    PubMed  Google Scholar 

  • Siesjö BK (1978) Brain energy metabolism and catecholaminergic activity in hypoxia, hypercapnia and ischemia. J Neural Transm [Suppl] 14: 17–22

    Google Scholar 

  • Slivka A, Brannan TS, Weinberger J, Knott PJ, Cohen G (1988) Increase in extracellular dopamine in the striatum during cerebral ischemia: a study utilizing cerebral microdialysis. J Neurochem 50: 1714–1718

    PubMed  Google Scholar 

  • Thompson PD, Marsden CD (1987) Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease. Mov Disord 2: 1–8

    PubMed  Google Scholar 

  • Tohgi H, Abe T, Takahashi S, Ueno M, Nozaki Y (1990) Cerebrospinal fluid dopamine, norepinephrine, and epinephrine concentrations in Parkinson's disease correlated with clinical symptoms. Adv Neurol 53: 277–282

    PubMed  Google Scholar 

  • Tohgi H, Abe T, Takahashi S, Nozaki Y, Kikuchi T (1991) Concentrations of tyrosine, L-dihydroxyphenylalanine, dopamine, and 3-O-methyldopa in the cerebrospinal fluid of Parkinson's disease. Neurosci Lett 127: 212–214

    PubMed  Google Scholar 

  • Tohgi H, Ueno M, Abe T, Takahashi S, Nozaki Y (1992) Concentrations of monoamines and their metabolites in the cerebrospinal foluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type. J Neural Transm [P-D Sect] 4: 69–77

    Google Scholar 

  • Tohgi H, Abe T, Takahashi S, Takahashi J, Hamato H (1993) Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett 150: 71–74

    PubMed  Google Scholar 

  • Tohgi H, Abe T, Takahashi S, Saheki M, Kimura M (1995) Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. J Neural Transm [P-D Sect] 9: 121–131

    Google Scholar 

  • Tolosa ES, Santamaria J (1984) Parkinsonism and basal ganglia infarcts. Neurology 34: 1516–1518

    PubMed  Google Scholar 

  • Tyce GM, Rorie DK, Byer DE, Danielson DR (1985) Free conjugated amines in human lumbar cerebrospinal fluid. J Neurochem 49: 322–324

    Google Scholar 

  • Weinberger J, Cohen G (1982) The differential effect of ischemia on the active uptake of dopamine, γ-aminobutyric acid, and glutamate by brain synaptosomes. J Neurochem 38: 963–968

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. H. Tohgi

    Present address: Department of Neurology, Iwate Medical University, Morioka, Japan

Affiliations

  1. Department of Neurology, Iwate Medical University, Morioka, Japan

    T. Abe, M. Saheki, K. Yamazaki & T. Murata

Authors
  1. H. Tohgi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Saheki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Murata
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tohgi, H., Abe, T., Saheki, M. et al. Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients. J. Neural Transmission 104, 441–449 (1997). https://doi.org/10.1007/BF01277662

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01277662

Keywords

  • Dopamine
  • L-dopa
  • 3-O-methyldopa
  • norepinephrine
  • serotonin
  • vascular parkinsonism
  • Parkinson's disease
  • cerebrospinal fluid